Regulatory Science Plan Would Create New Office In FDA
This article was originally published in The Gray Sheet
Executive Summary
Commissioner Margaret Hamburg released details of FDA's regulatory science plan Oct. 6, and said she is "guardedly optimistic" legislators will come up with the money needed to grow the agency's regulatory science capacity
You may also be interested in...
New NIH Center May Offer More Opportunity For FDA Collaboration
FDA hopes the National Institute of Health’s proposed new National Center for Advancing Translational Science will trigger more collaboration between the two agencies through shared grant making, FDA Commissioner Margaret Hamburg said last week.
New NIH Center May Offer More Opportunity For FDA Collaboration
FDA hopes the National Institute of Health’s proposed new National Center for Advancing Translational Science will trigger more collaboration between the two agencies through shared grant making, FDA Commissioner Margaret Hamburg said last week.
FDA Outlines Next Steps In Regulatory Science
FDA plans to invest in eight priority areas for regulatory science, including better tools for reviewing innovative technologies and new manufacturing approaches, according to a strategic plan released Aug. 17.